Core Insights - The report emphasizes the rapid development and significance of gene sequencing technologies in various fields, including drug development, environmental protection, and molecular biology research [3][4][6]. Gene Sequencing Technology Overview - Gene sequencing is defined as the process of analyzing the base sequence of specific segments of biological information, which is foundational for molecular biology research and genetic modification [3]. - The evolution of gene sequencing technologies can be categorized into three main types: Sanger sequencing, Next-Generation Sequencing (NGS), and Single-Molecule Sequencing, each with distinct characteristics and applications [3][4][5]. Comparison of Gene Sequencing Technologies - Sanger sequencing is recognized as the "gold standard" for DNA sequencing, offering high accuracy (99.99%) and is widely used in high-demand fields such as disease detection and antibody discovery [3][5]. - NGS technology allows for high-throughput processing of millions to billions of DNA fragments, significantly reducing sequencing costs and time, making it the mainstream technology for the foreseeable future [4][6]. - Single-Molecule Sequencing provides advantages in speed and long read lengths but currently lacks the commercial scalability and accuracy of NGS [5]. Market Overview and Trends - The gene sequencing market is driven by the demand from research institutions, hospitals, and biotechnology companies, with Sanger sequencing being crucial for high-accuracy verification in various applications [6][7]. - The growth of research funding in China, with annual increases of 10%-15%, is expected to continue, enhancing the demand for sequencing services as the research community expands [6]. Industry Demand and Growth Factors - The demand for gene sequencing services is increasing due to the growth in biopharmaceutical research and the need for accurate verification in in vitro diagnostic (IVD) products [7]. - The report highlights that the industrial research user demand, particularly from Contract Research Organizations (CROs), is driving the need for sequencing verification services [7].

Core Insights - The recent bio-manufacturing forum in Suzhou focuses on cutting-edge technologies and aims to facilitate technology transfer and industrial collaboration in the bio-manufacturing sector [1] - Bio-manufacturing is seen as a key driver of the "Fourth Industrial Revolution" and is crucial for developing new productive forces across various fields such as pharmaceuticals, agriculture, and food [1] - Suzhou Industrial Park is actively positioning itself in the bio-manufacturing sector, leveraging its strong industrial foundation and complete supply chain to seize development opportunities [1] Industry Development Plans - In March, Suzhou Industrial Park announced a three-year action plan to accelerate the development of the bio-manufacturing industry, focusing on synthetic biology, biopharmaceuticals, food, bio-based materials, and bio-manufacturing equipment [1][2] - The plan aims to enhance innovation capabilities, achieve scale effects, and improve the industrial ecosystem by 2027, with specific support in R&D, platform construction, innovation incubation, and collaborative development [2] Company Highlights - Suzhou has over 40 companies related to synthetic biology technology, accounting for nearly 60% of the total in the city [2] - Jinweizhi Biotechnology Co., Ltd. specializes in genomic research and technology applications, collaborating with 80% of the top 20 global pharmaceutical companies and serving multiple regions including China, North America, Europe, Southeast Asia, and Australia [2] - Jima Gene Co., Ltd. is a leading provider of RNA drug technology services in China, focusing on small nucleic acid technology and has established a pilot platform for nucleic acid drug research in collaboration with the National Biopharmaceutical Technology Innovation Center [3] Collaborative Models - The collaboration between national research centers and leading enterprises in Suzhou accelerates the overall industrial process of bio-manufacturing through a "national team + enterprise group" model [3] - The park plans to establish common technology platforms and resource libraries, including a microbial strain preservation library, to support high-throughput, intelligent, and automated pilot platforms [3]